Aksef - Indications: bacterial infections
Aksef axetil is indicated for the treatment of infections caused by sensitive bacteria. Lower respiratory tract infections for example, acute bronchitis, acute exacerbations of chronic bronchitis, and pneumonia. Upper respiratory tract infections for example, ear, nose, throat infections, such as otitis media, sinusitis, tonsillitis and pharyngitis. Genito-urinary tract infections for example, pyelonephritis, cystitis and urethritis. Skin and soft tissue infections for example, furunculosis, pyoderma and impetigo. Treatment of early Lyme disease and subsequent prevention of late Lyme disease in adults and children over 12 years old. Gonorrhoea acute uncomplicated gonococcal urethritis, and cervicitis. Cefuroxime is also available as the sodium salt (Zinacef) for parenteral administration. This permits the use of sequential therapy with the same antibiotic, when a change from parenteral to oral therapy is clinically indicated. Where appropriate this medicine is effective when used following initial parenteral Zinacef (cefuroxime sodium) in the treatment of pneumonia and acute exacerbations of chronic bronchitis.
Aksef sodium for injection is indicated for the treatment of infections caused by susceptible strains of the designated micro-organisms, or before the infecting organism has been identified, in the diseases listed below. Respiratory tract infections, for example, acute and chronic bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess and postoperative chest infections. Ear, nose and throat infections, for example, sinusitis, tonsillitis and pharyngitis. Urinary tract infections, for example, acute and chronic pyelonephritis, cystitis and asymptomatic bacteriuria. Soft tissue infections, for example, cellulitis, erysipelas, peritonitis and wound infections. Bone and joint infections, for example, osteomyelitis and septic arthritis. Obstetric and gynaecological infections, pelvic inflammatory disease. Gonorrhoea, particularly if penicillin is unsuitable. Other infections, including septicaemia and meningitis. Prophylaxis against infection in abdominal, pelvic, orthopaedic, cardiac, pulmonary, oesophageal and vascular surgery where there is increased risk from infection. Consideration should be given to official local guidance (eg, national recommendations) on the appropriate use of antibacterial agents. Susceptibility of the causative organism to the treatment should be tested (if possible), although therapy may be initiated before the results are available.